Navigation Links
Halting immune response could save brain cells after stroke
Date:3/13/2014

MADISON A new study in animals shows that using a compound to block the body's immune response greatly reduces disability after a stroke.

The study by scientists from the University of Wisconsin School of Medicine and Public Health also showed that particular immune cells CD4+ T-cells produce a mediator, called interleukin (IL) -21 that can cause further damage in stroke tissue. Moreover, normal mice, ordinarily killed or disabled by an ischemic stroke, were given a shot of a compound that blocks the action of IL-21. Brain scans and brain sections showed that the treated mice suffered little or no stroke damage.

"This is very exciting because we haven't had a new drug for stroke in decades, and this suggests a target for such a drug," says lead author Dr. Zsuzsanna Fabry, professor of pathology and laboratory medicine.

Stroke is the fourth-leading killer in the world and an important cause of permanent disability. In an ischemic stroke, a clot blocks the flow of oxygen-rich blood to the brain. But Fabry explains that much of the damage to brain cells occurs after the clot is removed or dissolved by medicine. Blood rushes back into the brain tissue, bringing with it immune cells called T-cells, which flock to the source of an injury.

The study shows that after a stroke, the injured brain cells provoke the CD4+ T-cells to produce a substance, IL-21, that kills the neurons in the blood-deprived tissue of the brain. The study gave new insight how stroke induces neural injury.

Fabry's co-author Dr. Matyas Sandor, professor of pathology and laboratory medicine, says that the final part of the study looked at brain tissue from people who had died following ischemic strokes. It found that CD4+ T-cells and their protein, IL-21 are in high concentration in areas of the brain damaged by the stroke.

Sandor says the similarity suggests that the protein that blocks IL-21 could become a treatment for stroke, and would likely be administered at the same time as the current blood-clot dissolving drugs.

"We don't have proof that it will work in humans," he says, "but similar accumulation of IL-21 producing cells suggests that it might."

Graduate student Benjamin S. D. Clarkson and scientist Changying Ling were key members of the UW research team, as was Dr. Dandan Sun, formerly of the UW neurosurgery department and now at the University of Pittsburgh, and Dr. Vijay Kuchroo, of the Harvard Medical School.

The paper was published this week in the Journal of Experimental Medicine. A link is available here: http://bit.ly/NToPfg


'/>"/>

Contact: Susan Lampert Smith
ssmith5@uwhealth.org
608-890-5643
University of Wisconsin-Madison
Source:Eurekalert

Related medicine news :

1. ACP, others oppose paying for fiscal cliff by halting Medicaid primary care fee increases
2. MD Anderson, MedImmune join forces to advance cancer immunotherapy
3. Cancer vaccine could use immune system to fight tumors
4. Vitamin A may help boost immune system to fight tuberculosis
5. Immune cells need a second opinion
6. Benaroya Research Institute receives 7-year award to lead Immune Tolerance Network
7. FASEB announces 2014 Science Research Conference: Biology of the Immune System
8. Voices Against Brain Cancer Comments On How Boosting One’s Immune System Can Help Fight Tumor Growth
9. Platinum Soursop: The Natural Health Supplement Helps to Improve Cells Functions & Supports Immune System Now with 1 Extra Bottle Offer
10. Does the bodys immune response to viral vector delivery systems affect the safety or efficacy of gene therapy?
11. Platinum Soursop-The natural health supplement to improve immune system and enhance Mood is finally available for purchase
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... , ... January 18, 2017 , ... ... Fischell Department of Bioengineering are collaborating on a research project focused on multiple ... the project seeks to use nanotechnology to control the disease without compromising normal ...
(Date:1/18/2017)... ... January 18, 2017 , ... The V Foundation for ... V, its official endurance training and fundraising team, to compete in the Boston Marathon ... those inspired to finish the world’s oldest annual marathon to join Team V and ...
(Date:1/18/2017)... ... January 18, 2017 , ... The Portee Insurance Agency, ... and business owners in central Maryland and the DC region, is inaugurating a charity ... 787,000 people nationally every year, making it the #1 killer in America. However, heart ...
(Date:1/18/2017)... ... January 18, 2017 , ... Dr. Farhan Qureshi is an esteemed dentist who ... modern dental practice has two convenient office locations in Alexandria and Arlington, Virginia. Recently, ... for the Alexandria area. This award confirms the fact that Dr. Qureshi’s patients ...
(Date:1/18/2017)... ... January 18, 2017 , ... The Hear the World Foundation, ... the donation of cochlear implants. In February 2017, the first three children with ... chance of leading an independent life. This engagement builds on the support the ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... VILLAGE, Colo. , Jan. 18, 2017 ... independent chain of pharmacies based in Loveland, ... Rx™ Locking Prescription Vials (LPVs) in selected Good Day locations.   ... now have a cost-effective alternative for secure storage," said ... Rx.  "For less than the price of a cup ...
(Date:1/18/2017)... Invetech, the leading developer of ... , has announced a collaboration agreement with Erytech ... treatments for acute leukemia and other oncology indications ... will develop systems to enable the commercial-scale manufacture ... platform, which uses a novel technology to encapsulate ...
(Date:1/18/2017)... -- After the recent election cycle, it is ... both for medical and recreational purposes are shifting. The evidence ... use of cannabis, but the focus is coming from both ... the North American legal cannabis market posted $6.7 billion in ... research projects sales will grow at a compound annual growth ...
Breaking Medicine Technology: